Aesica has plans to grow and expand following a significant investment from Silverfleet Capital, a European private equity firm. Silverfleet Capital has agreed to a majority investment in Aesica and members of Aesica have reinvested for a large minority stake in the company. The investment will allow Aesica to continue its expansion into new markets and grow its position as a major supplier of APIs and Formulated Products to the global pharmaceutical industry. Aesica has six manufacturing sites...